These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 18949510)

  • 21. Review: treatment of gastroesophageal reflux disease in the elderly.
    Poh CH; Navarro-Rodriguez T; Fass R
    Am J Med; 2010 Jun; 123(6):496-501. PubMed ID: 20569750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease.
    Mearin F; Ponce J; Ponce M; Balboa A; Gónzalez MA; Zapardiel J
    Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):665-74. PubMed ID: 22330237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease.
    Gold BD; Pilmer B; Kierkuś J; Hunt B; Perez MC; Gremse D
    Dig Dis Sci; 2017 Nov; 62(11):3059-3068. PubMed ID: 28916953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing symptoms in gastroesophageal reflux disease: how well do clinicians' assessments agree with those of their patients?
    McColl E; Junghard O; Wiklund I; Revicki DA
    Am J Gastroenterol; 2005 Jan; 100(1):11-8. PubMed ID: 15654774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of symptoms in step-down therapy of gastroesophageal reflux disease.
    Mine S; Iida T; Tabata T; Kishikawa H; Tanaka Y
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1365-70. PubMed ID: 16105122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Heartburn: in short-term treatment you have the choice!].
    Camain JY; Wiesel PH; Peytremann-Bridevaux I
    Praxis (Bern 1994); 2012 Feb; 101(5):331-2. PubMed ID: 22377981
    [No Abstract]   [Full Text] [Related]  

  • 28. Characteristics of gastroesophageal reflux in adults with cystic fibrosis.
    Sabati AA; Kempainen RR; Milla CE; Ireland M; Schwarzenberg SJ; Dunitz JM; Khan KM
    J Cyst Fibros; 2010 Sep; 9(5):365-70. PubMed ID: 20674518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of antireflux treatment on the frequency of awakenings from sleep in patients with Gastroesophageal reflux disease.
    Jha LK; Maradey-Romero C; Gadam R; Hershcovici T; Fass OZ; Quan SF; Guillen J; Fass R
    Neurogastroenterol Motil; 2015 Feb; 27(2):237-45. PubMed ID: 25484104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study.
    Rush DR; Stelmach WJ; Young TL; Kirchdoerfer LJ; Scott-Lennox J; Holverson HE; Sabesin SM; Nicholas TA
    J Fam Pract; 1995 Aug; 41(2):126-36. PubMed ID: 7636452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of gastroesophageal reflux in a Tunisian primary care population determined by patient interview.
    Ben Chaabane N; El Jeridi N; Ben Salem K; Hellara O; Loghmari H; Melki W; Bdioui F; Safer L; Soltani M; Saffar H
    Dis Esophagus; 2012 Jan; 25(1):4-9. PubMed ID: 21595777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of intermittent reflux symptoms: one size does not fit all.
    DeVault KR
    J Clin Gastroenterol; 2007 Jul; 41(6):546-7. PubMed ID: 17577109
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevalence of gastroesophageal reflux disease in Moscow.
    Bor S; Lazebnik LB; Kitapcioglu G; Manannikof I; Vasiliev Y
    Dis Esophagus; 2016; 29(2):159-65. PubMed ID: 25604401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial.
    Manabe N; Haruma K; Ito M; Takahashi N; Takasugi H; Wada Y; Nakata H; Katoh T; Miyamoto M; Tanaka S
    Dis Esophagus; 2012 Jul; 25(5):373-80. PubMed ID: 22050449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gastroesophageal reflux in the French general population: national survey of 8000 adults].
    Bretagne JF; Richard-Molard B; Honnorat C; Caekaert A; Barthélemy P
    Presse Med; 2006 Jan; 35(1 Pt 1):23-31. PubMed ID: 16462660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marked increase in proton pump inhibitors use in Australia.
    Hollingworth S; Duncan EL; Martin JH
    Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):1019-24. PubMed ID: 20623646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoluminal gastroplication for the treatment of gastroesophageal reflux disease: a 2-year prospective pilot study from Taiwan.
    Liao CC; Lee CL; Lin BR; Bai CH; Hsieh YH; Wu CH; Gostout CJ
    J Gastroenterol Hepatol; 2008 Mar; 23(3):398-405. PubMed ID: 18318824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of clinical features in patients with eosinophilic esophagitis living in an urban and rural environment.
    Lee YJ; Redd M; Bayman L; Frederickson N; Valestin J; Schey R
    Dis Esophagus; 2015 Jan; 28(1):19-24. PubMed ID: 24382218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heartburn in patients with gastro-oesophageal reflux disease in Germany and Sweden: a study on patients' burden of disease.
    Jones R; Horbach S; Sander P; Rydén-Bergsten T
    Pharmacoeconomics; 2003; 21(15):1091-102. PubMed ID: 14596628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the primary care provider in the diagnosis and management of heartburn.
    Kushner PR
    Curr Med Res Opin; 2010 Apr; 26(4):759-65. PubMed ID: 20095795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.